What is Stereotaxis?
Stereotaxis is a global leader in the development and delivery of innovative robotic systems designed for minimally invasive endovascular procedures. The company's core technology provides physicians with enhanced control, robotic precision, and improved safety profiles during complex interventions. By focusing on the interventional laboratory, Stereotaxis aims to expand access to advanced surgical care while simultaneously enhancing the productivity and intelligence of the modern operating room. Its market position is defined by a unique blend of robotics, digital connectivity, and clinical efficacy, which serves to improve patient outcomes and streamline hospital workflows.
How much funding has Stereotaxis raised?
Stereotaxis has raised a total of $497.1M across 23 funding rounds:
Stock Offering
$10.2M
Debt
$10M
Share Placement
$24M
Other Financing Round
$10M
Share Placement
$25M
Debt
$2M
Share Placement
$15M
Other Financing Round
$50M
Stock Issuance/Offering (2013): $10.2M with participation from Undisclosed
Debt (2014): $10M led by Silicon Valley Bank
Share Placement (2016): $24M supported by DAFNA Capital Management and Joe Kiani
Other Financing Round (2018): $10M featuring Undisclosed
Share Placement (2019): $25M backed by Opaleye Management, Parkman Healthcare Partners, and Redmile Group
Debt (2020): $2M with participation from PPP
Share Placement (2020): $15M led by Consonance Capital Management
Other Financing Round (2025): $50M supported by Roth Capital Partners
Key Investors in Stereotaxis
Advent International
Advent International is a global private equity investment firm that provides capital and strategic support to businesses across multiple industries and geographies. The firm partners with management teams to invest in, transform, and scale companies through buyouts, growth investments, carve-outs, and other complex transactions.
Johnson & Johnson Development Corporation
Johnson & Johnson is a global healthcare company that develops pharmaceuticals and medical technologies. It provides innovative medicines, surgical products, and medical devices used in areas such as oncology, immunology, neuroscience, and cardiovascular care, serving healthcare providers and patients worldwide.
Ascension Ventures
Ascension Ventures is a strategic healthcare venture firm that collaborates with leading community health systems to identify, invest in, and support private companies that are transforming the healthcare industry and enhancing the patient experience.
What's next for Stereotaxis?
With the recent infusion of capital, Stereotaxis is well-positioned to accelerate its strategic roadmap, focusing on the next generation of robotic instruments and data-driven surgical intelligence. The company is expected to prioritize the scaling of its commercial operations and the further integration of its robotic systems into leading healthcare networks. As the demand for minimally invasive, high-precision surgical solutions continues to rise, Stereotaxis is poised to leverage its robust intellectual property portfolio and established clinical partnerships to maintain its competitive edge. Future initiatives will likely center on expanding the clinical utility of its platforms, thereby reinforcing its role as a critical infrastructure provider in the evolving landscape of cardiovascular and endovascular care.
See full Stereotaxis company page
